Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus.

Laorden, M L; Castells, M T; Martínez, M D; Martínez, P J; Milanés, M V

Laorden, M L; Castells, M T; Martínez, M D; Martínez, P J; Milanés, M V.

Affiliation

Laorden ML; Department of Physiology and Pharmacology, University School of Medicine, Murcia, Spain.

Endocrinology ; 141(4): 1366-76, 2000 Apr.

Article in En | MEDLINE | ID: mdl-10746640

Subject(s)

Paraventricular Hypothalamic Nucleus/metabolism; Proto-Oncogene Proteins c-fos/metabolism; Receptors, Opioid, kappa/agonists; Receptors, Opioid, mu/agonists; Suprachiasmatic Nucleus/metabolism; Supraoptic Nucleus/metabolism; 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer/pharmacology; Animals; Male; Methoxyhydroxyphenylglycol/metabolism; Morphine/pharmacology; Naloxone/pharmacology; Naltrexone/analogs & derivatives; Naltrexone/pharmacology; Narcotic Antagonists/pharmacology; Narcotics/pharmacology; Norepinephrine/metabolism; Paraventricular Hypothalamic Nucleus/drug effects; Proto-Oncogene Proteins c-fos/antagonists & inhibitors; Rats; Rats, Sprague-Dawley; Suprachiasmatic Nucleus/drug effects; Supraoptic Nucleus/drug effects

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Paraventricular Hypothalamic Nucleus / Suprachiasmatic Nucleus / Supraoptic Nucleus / Proto-Oncogene Proteins c-fos / Receptors, Opioid, kappa / Receptors, Opioid, mu Limits: Animals Language: En Journal: Endocrinology Year: 2000 Document type: Article Affiliation country: Spain

Search on Google

Add to My VHL

XML

PubMed Links